AMCOL International Presents at European Medical Conference

Scientists, health care professionals and government representatives attend the Conference with the goal of combating the influenza epidemic.  Dr. John Oxford, Retroscreen scientific director and Professor of Virology at Queen Mary's School of Medicine & Dentistry at the University of London, is a co-organizer of this conference.  For additional information on the European Influenza Conference, please visit the website at
http://www.eswiconference.org .

The poster entitled, "Evaluation of the antiviral activity of different modifications of nano-bentonite clay against the Human Influenza (H3N2) Virus, Avian Influenza (H5N1) Virus and the Human Immunodeficiency Virus" outlines reduction in viral activity of selected viruses from AMCOL modified bentonites.  Certain products are available in commercial quantities pending
regulatory reviews, and patents have been applied for.  No animal or human testing has been conducted.  The poster can be viewed at http://www.amcol.com .

Larry Washow, AMCOL president and chief executive officer, said, "The data from this testing provided clinical validation that nano-bentonites have the ability to inactivate a number of viruses.  This is a very important development in our continuing work with nano-bentonites, a completely new direction in the evolving field of nano-material use in health-related applications.  It will take quite some time to see these products reach the marketplace as further work will be required on these initial lab tests."
AMCOL International Corp. produces and markets specialty mineral products used for industrial, environmental and consumer-related applications.  The company operates in three industry segments, minerals, environmental and transportation.  AMCOL's common stock is traded on the New York Stock Exchange under the symbol "ACO."  The Company's website is http://www.amcol.com .

Founded in 1989, Retroscreen Virology Ltd. is an independent contract research virology company which specializes in developing anti-viral compounds and vaccines.  Retroscreen has worked with many large pharmaceutical companies to assist them in developing products that help to fight viral diseases worldwide.  These include influenza, HIV and now SARS.  The Company's website is http://www.retroscreen.com .